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growth of cancer cells in time and dose dependent manners with an
IC50 about 400 mg/ml.
Flow cytometry analysis: Flow cytometry result show that with
increasing concentration of treatment SubG1 peak shows a significant
increase from 16.2% to 94.8%. The SubG1 peak in IC50 have been
reported of about 69%.
Discussion:Lately, the synthesis of ligands andmetal complexes for
medical and industrial applications has attracted much attention. So far,
many studies have been done in the field of anti-cancer effects of vari-
ous complexes of Schiff bases. Ssynthesized copper (II) complexes of
schiff bases are able to prevent the growth of HepG2 cancer cells. Farag
and et al studied proapoptotic effects of Cu,Mn, Zn complexes of schiff
base on HepG2 cells and showed that Zn (II) and Cu (II) complexes
have a noticeable antiproliferative (IC50¼ 4.6 lg/mL) and proapoptotic
effect on HepG2 cells. However, some of these compounds inhibited
viability of cells and induced apoptosis through activation of caspase
pathway. Findings from another study showed that some complexes
of morpholine Schiff bases have antiproliferative effect onMCF7 cells.
IC50 of Mn(L1)Cl, Cu(L1)Cl and Zn(L1)Cl were about 24.54, 37.58
and 10.94mg/ml, smaller than Mn2+ Complex of the N, N0-dipyridoxyl
(1, 2-diaminobenzene) Schiff Base in the present study.
Conclusions: The Mn2+ complex of the N, N0-dipyridoxyl (1, 2-
diaminobenzene) Schiff base showed anti-proliferative activity on
MCF7 cells and induced apoptosis in these cells.
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Fig. 1. Morphological alterations in MCF7 cells at different concentrations of
Schiff base (0,400 and 800 mg/ml). Reduction in the number, size and shape of
the cells is visible (Scale bar: 20mm).
Fig. 2. Anti-proliferative effect of Mn2+ complex schiff base on MCF7 cells
after 24 and 48h treatment. Results are expressed as mean ± SD
(***P<0.001 is significant).
Fig. 3. Flow cytometry assay of MCF7 cells that treated with different concen-
tration of Schiff base. The SubG1 peak increased with increasing concentra-
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Extended Abstract
Introduction: Esophageal cancer (EC) is the eighth most com-
mon type of malignancy and is the sixth leading cause of cancer-
related mortality worldwide. The average 5-year survival rate is
only seen in 35-45% of patients. In Iran esophageal cancer is the
4th common cancer in women and sixth cause of death in men.
The incidence rate of EC varies considerably from one country to
another. The high-risk area for ES is extending from northern Iran
to north-central China (Asian belt of EC).
EC is considered as growing health concern and its incidence is
expected to be increased by 140% by 2025.
Two main forms of esophageal cancer are squamous cell carci-
noma (ESCC) and adenocarcinoma (ADC). More than 90% of all
diagnosed esophageal cancers in Iranian patient are the squamous
cell type.
Several risk factors have been investigated as possible etiologic
factors for esophageal squamous cell carcinoma. In Iran, many risk
factors contributing to the development of squamous cell carcinoma
of the esophagus are evaluated. Alcohol is rarely consumed by men
in Northeastern Iran, neither women. The proposed risk factors in Ira-
nian patients include a low intake of fruits and vegetables, the con-
sumption of very hot beverages, exposure to carcinogens due to
opium consumption, tobacco smoking, nass chewing and low socio-
economic status may play roles in development of ESCC.
Moreover genetic susceptibility was suggested to play an impor-
tant role in pathogenesis of ESCC. So, we can consider ESCC as a
complex and multifactorial disease. Several studies have conducted
to find out biomarkers for ESCC. In this review we have listed
some important biomarkers of ESCC patient in Iranian population.
In this regard, abnormal activity of major cell signaling pathways
such as Apoptosis, Notch and Wnt plays important roles in ESCC
progression. Dysregulation of some of these important signaling path-
ways is involved in tumorigenesis.
Table 1 Important biomarkers in ESCC patient in Iran. We used
DAVID pipeline to identify pathways that these biomarkers are
involved.
Wnt, Notch and Apoptosis signaling pathways play an important
role in cell fate decision during development. Besides, Wnt signaling
is an important pathway that is involved in determination of cellular
development, self-renewal, and fate, and also tumor development and
progression.
As a result, based on the fact that no standard early diagnostic
guideline has been proposed to date and current therapeutic modal-
ities are not efficient, detection of specific biomarkers could be of
great value in the early diagnosis ESCC. Therefore, in this review
Table 1 Important biomarkers in ESCC patient and their important role.
Biomarkers Wnt signaling
pathway
Notch signaling
pathway
Apoptosis signaling
pathway
Roles in ESCC
HEY1 ✓ Over-expression of HEY1 in ESCC is correlated to different indices of poor prognosis
HEY2 ✓ Over-expression of HEY2 in ESCC is correlated to different indices of poor prognosis
CD44 ✓ ✓ Up-regulation of CD44 in ESCC samples
MDM2 ✓ ✓ ✓
HES1 ✓ ✓ HES1 under-expression was significantly correlated with tumor depth of invasion
MUC1 ✓ ✓ Specific MUC1 splice variants are correlated with tumor progression in ESCC
SALL4 ✓ ✓ SALL4wasover-expressed and have a significant correlation with invasion and
metastasis in ESCC
SOX2 ✓ ✓ ✓ SOX2 was over-expressed and have a significant correlation with invasion and
metastasis in ESCC
Msi1 ✓ ✓ ✓ Msi1 was significantly over-expressed in 41.5% of ESCC tumor sample
MMP2 ✓ ✓ MMP2 was significantly over-expressed and it could be used as specific diagnostic,
prognostic and therapeutic biomarker for ESCC
HLA-G ✓ HLA-G was significantly over-expressed and it could be used as specific diagnostic,
prognostic and therapeutic biomarker for ESCC
XRCC5 ✓ ✓ XRCC5 was significantly over-expressed and it could be used as specific diagnostic,
prognostic and therapeutic biomarker for ESCC
MAML1 ✓ ✓ MAML1 was significantly over-expressed in ESCC patient and significantly
associated with lymph node metastasis and the surgical staging of tumor
TWIST1 ✓ ✓ ✓ TWIST1 was significantly over-expressed in ESCC patient and associated with lymph
node metastasis and the surgical staging of tumor
p53/P21 ✓ ✓ ✓ p53 and p21 expression play an important role in ESCC development in northeastern
Iran(36)
GSTP1 ✓ Exposure to some cigarette related pro-carcinogens could activate GSTP1 domain,
which may responsible for the increased susceptibility to ESCC(37)
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association with three signaling pathways.
Conclusion: These biomarkers had a strong prognostic value in
ESCC. The rising incidence and poor prognosis of ESCC in Western
countries have intensified research efforts for developing earlier
methods of disease detection. It is well recognized that early diagno-
sis of cancer can provide the means for the full recovery of patients.
However, conventional methods of cancer screening are often inva-
sive and expensive. Sensitivity and specificity of these methods are
also insufficient for the diagnosis of cancer at earlier stages.
In addition, we found some other related biomarkers such as Brg1,
LAGE1, p21, MAGE-A4, NY-ESO1, P16, D44V3, IL-10, TGF-beta
and VEGF, showed important effects on survival, disease progression
and clinicopathological characteristics of ESCC patients.
Actually, alteration in the expression of p53 tumor-suppressor pro-
tein is an event that occurs frequently in human cancer, but the prac-
tical implications of this phenomenon are yet to be fully exploited. It
has been shown that the p53 and p16 tumor suppressor genes are
involved in the cell cycle control and protecting cells exposed to
DNA-damaging agents. Moreover, SOX2 is an important key tran-
scription factor involved in self-renewal and pluripotency characteris-
tics of undifferentiated ESCCs. In addition, it is a member of master
transcriptional complex consisting of OCT4/SOX2/NANOG which
can reprogram differentiated cells to induced pluripotent stem cells.
Nonetheless, TWIST is among the proteins that induce and pro-
mote epithelial mesenchymal transition (EMT). Up-regulation of
TWIST1 has been suggested to enhance invasion and metastatic abil-
ity of various types of tumor cells including ESCC.
CD44 is a member of the cell adhesion molecules family. Natu-
rally, CD44 influences cell motility, migration, and adhesion, while
in tumor cells it leads to tumor invasion, progression, and
metastasis.Although significant advances have been made in the treatment of
ESCC, this aggressive malignancy commonly presents as a locally
advanced disease with a poor prognosis. Despite the advances in the
detection of premalignant pathology and newer preventative strategies,
these biomarkers are of high significance in disease prognosis. With a
poor prognosis, EC poses a great burden on societies, particularly East-
ern Asian countries. However, so far, no clinically approved biomarker
has been identified for an early medical intervention.
Based on our study,wefind that somebiomarkers are correlatedwith
late stage, depth of invasion and unfavorable response to chemotherapy
such as LgR5. These markers cannot be recommended for clinical
application due to absence of sufficient clinical investigations and sci-
entific reports and undetermined specificity and sensitivity in compar-
ison with standardmethods. This study can be considered as a source of
Biomarkers evaluation, which is a useful and valuablemeans for cancer
management. Overall, biomarker analysis can lead to novel biomarker
panels which can be useful in order to increase the overall survival rate.
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